Preview Mode Links will not work in preview mode
  1. All Episodes
  2. ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Nov 26, 2024

Featuring an interview with Dr Seth Wander, including the following topics:

  • ASCO Guidelines Rapid Recommendations Update for Testing for ESR1 Mutations (0:00)
  • Real-world elacestrant use patterns and genomic biomarkers (4:43)
  • Circulating tumor DNA (ctDNA) analyses with imlunestrant in the EMBER Phase I study (8:50)

CME information and select publications